No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Methylin is a brand of methylphenidate, a central nervous system stimulant used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. It is also used off-label to treat depression and other mental disorders. Methylin is available in both immediate-release and extended-release formulations. The immediate-release form is taken two to three times a day, while the extended-release form is taken once daily. Methylin is available in tablet, chewable tablet, and liquid forms.
Methylin is part of a larger market of mental disorder drugs, which includes other stimulants such as Adderall and Ritalin, as well as non-stimulants such as Strattera and Intuniv. These drugs are used to treat a variety of mental disorders, including ADHD, depression, anxiety, and bipolar disorder.
The companies in the Methylin market include Mallinckrodt Pharmaceuticals, Actavis, and Kremers Urban Pharmaceuticals. Show Less Read more
